Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

OBJECTIVE: Cotadutide, a dual GLP-1 and glucagon receptor agonist, is under development for nonalcoholic steatohepatitis (NASH) and chronic kidney disease with type 2 diabetes. The effects of cotadutide on hepatic and metabolic parameters were evaluated in participants with overweight/obesity and ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Nahra, Rajaa, Wang, Tao, Gadde, Kishore M., Oscarsson, Jan, Stumvoll, Michael, Jermutus, Lutz, Hirshberg, Boaz, Ambery, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247525/
https://www.ncbi.nlm.nih.gov/pubmed/34016612
http://dx.doi.org/10.2337/dc20-2151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247525/
https://www.ncbi.nlm.nih.gov/pubmed/34016612
http://dx.doi.org/10.2337/dc20-2151

Ejemplares similares